AstraZeneca
The Global Development Medical Director, Hematology at AstraZeneca will lead clinical strategy and execution for hematology oncology programs, providing medical oversight, protocol development, and safety monitoring across early and late‑phase trials. The role collaborates cross‑functionally with clinical, regulatory, and commercial teams to ensure scientific rigor and compliance with global regulations.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
AstraZeneca didn’t post a salary, so this is our estimate from similar listings.
6% below the average for this role
Global Development Medical Director, Hematology Oncology
lifelancer
Global Development Medical Director, Hematology Oncology
lifelancer
Global Development Medical Director, Hematology Oncology
American Association of Physicists in Medicine
Global Development Senior Medical Director, Hematology Oncology
lifelancer
Medical Director For Utah Based Oncology-Hematology Pharmaceutical Company
Archer
Medical Director, Hematology Clinical Development
AbbVie